AU2003300031A1 - Compounds, compositions, and methods - Google Patents

Compounds, compositions, and methods

Info

Publication number
AU2003300031A1
AU2003300031A1 AU2003300031A AU2003300031A AU2003300031A1 AU 2003300031 A1 AU2003300031 A1 AU 2003300031A1 AU 2003300031 A AU2003300031 A AU 2003300031A AU 2003300031 A AU2003300031 A AU 2003300031A AU 2003300031 A1 AU2003300031 A1 AU 2003300031A1
Authority
AU
Australia
Prior art keywords
compositions
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300031A
Other languages
English (en)
Other versions
AU2003300031A8 (en
Inventor
Gustave Bergnes
David J. Morgans Jr.
Xiangping Qian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytokinetics Inc
Original Assignee
Cytokinetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytokinetics Inc filed Critical Cytokinetics Inc
Publication of AU2003300031A1 publication Critical patent/AU2003300031A1/en
Publication of AU2003300031A8 publication Critical patent/AU2003300031A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003300031A 2002-10-11 2003-10-09 Compounds, compositions, and methods Abandoned AU2003300031A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41803002P 2002-10-11 2002-10-11
US60/418,030 2002-10-11
PCT/US2003/032318 WO2004032879A2 (en) 2002-10-11 2003-10-09 Compounds, compositions, and methods

Publications (2)

Publication Number Publication Date
AU2003300031A1 true AU2003300031A1 (en) 2004-05-04
AU2003300031A8 AU2003300031A8 (en) 2004-05-04

Family

ID=32094139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300031A Abandoned AU2003300031A1 (en) 2002-10-11 2003-10-09 Compounds, compositions, and methods

Country Status (5)

Country Link
US (1) US7271167B2 (https=)
EP (1) EP1558589A4 (https=)
JP (1) JP2006502230A (https=)
AU (1) AU2003300031A1 (https=)
WO (1) WO2004032879A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505728B2 (en) 2012-03-09 2016-11-29 Inception 2, Inc. Triazolone compounds and uses thereof
US9676754B2 (en) 2012-12-20 2017-06-13 Inception 2, Inc. Triazolone compounds and uses thereof
US9776976B2 (en) 2013-09-06 2017-10-03 Inception 2, Inc. Triazolone compounds and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007518711A (ja) 2003-12-19 2007-07-12 メルク　エンド　カムパニー　インコーポレーテッド 有糸分裂キネシン阻害剤
CN101027309B (zh) 2004-08-18 2010-10-27 阿斯利康(瑞典)有限公司 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
EP2070932A1 (en) * 2007-12-13 2009-06-17 4Sc Ag Pyrazolotriazines
US8901122B2 (en) 2012-12-20 2014-12-02 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125747A (en) * 1975-02-14 1976-11-02 Sumitomo Chem Co Ltd Aherbicidal and non-medical germicide
GB1501811A (en) * 1975-01-21 1978-02-22 Sumitomo Chemical Co Biocidal uses of pyridyltriazinone compounds
AU535319B2 (en) * 1979-12-03 1984-03-15 Sumitomo Chemical Company, Limited 1,2,4-imazine derivatives
FR2769912B1 (fr) * 1997-10-16 2000-03-10 Pf Medicament Nouveaux derives de la 3-oxo- (2h)-1,2,4 triazine leur preparation et leur application en therapeutique humaine
US20050107404A1 (en) * 2001-12-06 2005-05-19 Fraley Mark E. Mitotic kinesin inhibitors
DE10230604A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Heterocyclisch substituierte Imidazotriazine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9505728B2 (en) 2012-03-09 2016-11-29 Inception 2, Inc. Triazolone compounds and uses thereof
US9676754B2 (en) 2012-12-20 2017-06-13 Inception 2, Inc. Triazolone compounds and uses thereof
US10568871B2 (en) 2012-12-20 2020-02-25 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
US11666557B2 (en) 2012-12-20 2023-06-06 Tempest Therapeutics, Inc. Triazolone compounds and uses thereof
US9776976B2 (en) 2013-09-06 2017-10-03 Inception 2, Inc. Triazolone compounds and uses thereof

Also Published As

Publication number Publication date
EP1558589A4 (en) 2008-01-09
US7271167B2 (en) 2007-09-18
JP2006502230A (ja) 2006-01-19
US20060173007A1 (en) 2006-08-03
WO2004032879A2 (en) 2004-04-22
EP1558589A2 (en) 2005-08-03
AU2003300031A8 (en) 2004-05-04
WO2004032879A3 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2003262747A1 (en) Compounds, compositions, and methods
AU2003236527A1 (en) Compounds, compositions, and methods
AU2003265242A1 (en) Compounds, compositions, and methods
AU2003270015A1 (en) Compounds, compositions, and methods
AU2003299612A1 (en) Compounds, compositions and methods
EP1503993A4 (en) COMPOUNDS, METHODS AND COMPOSITIONS
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
AU2003285288A1 (en) Composition
IL164581A0 (en) Compounds, compositions and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003277079A1 (en) Compounds, compositions, and methods
AU2002950744A0 (en) Composition
AU2003235708A1 (en) Polytartrate composition
AU2003290507A1 (en) Compounds, compositions and methods
IL167936A0 (en) Compounds, compositions,and methods
AU2003208411A1 (en) Anti-glycolytic composition
AU2003269904A1 (en) Antigen-polymer compositions
AU2003267169A1 (en) Compounds, compositions and methods
AU2003300031A1 (en) Compounds, compositions, and methods
AU2002953252A0 (en) Compositions, Compounds and Methods for their Preparation
AU2003208841A1 (en) Gasolinen compositions
AU2003268772A1 (en) Oil-barrier composition
AU2003216382A1 (en) Idothyronine compositions
AU2003218497A1 (en) FACTORVIIa COMPOSITIONS
HK1074835A (en) Compounds, compositions, and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase